The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Nonparametric Estimation from Incomplete Observations
Abstract
In lifetesting, medical follow-up, and other fields the observation of the time of occurrence of the event of interest (called a death) may be prevented for some of the items of the sample by the previous occurrence of some other event (called a loss). Losses may be either accidental or controlled, the latter resulting from a decision to terminate certain observations. In either case it is usually assumed in this paper that the lifetime (age at death) is independent of the potential loss time; in practice this assumption deserves careful scrutiny. Despite the resulting incompleteness of the data, it is desired to estimate the proportion P(t) of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t). The observation for each item of a suitable initial event, marking the beginning of its lifetime, is presupposed. For random samples of size N the product-limit (PL) estimate can be defined as follows: List and label the N observed lifetimes (whether to death or loss) in order of increasing magnitude, so that one has 0≤t 1ǐ≤t 2ǐ≤ … ≤t N ǐ. Then P(t)= II. [(N – r)/(N – r + 1)], where r assumes those values for which tr ≤t and for which tr ǐ measures the time to death. This estimate is the distribution, unrestricted as to form, which maximizes the likelihood of the observations. Other estimates that are discussed are the actuarial estimates (which are also products, but with the number of factors usually reduced by grouping); and reduced-sample (RS) estimates, which require that losses not be accidental, so that the limits of observation (potential loss times) are known even for those items whose deaths are observed. When no losses occur at ages less than t, the estimate of P(t) in all cases reduces to the usual binomial estimate, namely, the observed proportion of survivors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This 1-year persistence rate is substantially lower than the more than 85% persistence rate reported in many weight loss GLP-1 treatment RCTs 7,13,[27][28][29] and the real-world diabetes treatment GLP-1 studies with around 50% persistent.15,16”
From Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. (2024) · cites this paper as [15]
In the citing paper
“Real-world T2DM treatment GLP-1 studies have found 1 year persistence rates at around 50%. 15,16”
From Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. (2024) · cites this paper as [15]
Citations
Cites
Journal of The American Statistical Association
Fienberg, S. E. (2004) · Encyclopedia of Statistical Sciences · doi:10.1002/0471667196.ess1317 · Cited by 6,289
Survival curve for cancer patients following treatment
Berkson, J., & Gage, R. P. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10501187 · Cited by 889
Epstein, B., & Sobel, M. (1953) · Journal of the American Statistical Association · doi:10.1080/01621459.1953.10483488 · Cited by 485
An Analysis of Some Failure Data
Davis, D. J. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10501160 · Cited by 452
Some Theorems Relevant to Life Testing from an Exponential Distribution
Epstein, B., & Sobel, M. (1954) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177728793 · Cited by 319
Irwin, J. O. (1949) · Journal of Hygiene · doi:10.1017/s0022172400014443 · Cited by 182
THE NATURAL DURATION OF CANCER.
(1926) · The Lancet · doi:10.1016/s0140-6736(01)26538-6 · Cited by 163
Epstein, B., & Sobel, M. (1953) · Journal of the American Statistical Association · doi:10.2307/2281004 · Cited by 162
Stephan, F. F. (1945) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177731170 · Cited by 119
XXVII. On the statistical estimation of mean life-times
Bartlett, M. S. (1953) · The London Edinburgh and Dublin Philosophical Magazine and Journal of Science · doi:10.1080/14786440308520304 · Cited by 96
Research works printed but not linked: 12
- Berkson , J. and Gage , R. P. 1950 . “Calculation of survival rates for cancer,” . Proceedings of the Staff Meetings of the Mayo Clinic , 25 : 270 – 86 . · DOI
- Böhmer , P. E. 1912 . “Theorie der unabhängigen Wahrscheinlichkeiten,” 327 – 43 . Rapports, Mémoires et Procès-verbaux de Septième Congrès International d'Actuaires, Amsterdam, 2
- Cornfield , J. 1950 . “Cancer illness among residents in Atlanta, Georgia,” Public Health Service Publication No. 13, Cancer Morbidity Series No. 1
- Fix , Evelyn . “Practical implications of certain stochastic models on different methods of follow-up studies,” . Paper presented at 1951 annual meeting of the Western Branch . 1951 . November 1 . American Public Health Association .
- Fix , Evelyn and Neyman , J. 1951 . “A simple stochastic model of recovery, relapse, death and loss of patients,” . Human Biology , 23 : 205 – 41 .
- Greville , T. N. E. 1948 . “Mortality tables analyzed by cause of death,” . In The Record , Vol. 37 , 283 – 94 . American Institute of Actuaries .
- Hald , A. 1949 . “Maximum likelihood estimation of the parameters of a normal distribution which is truncated at a known point,” . Skandinavisk Aktuarietidskrift , 32 : 119 – 34 .
- Harris , T. E. , Meier , P. and Tukey , J. W. 1950 . “Timing of the distribution of events between observations,” . Human Biology , 22 : 249 – 70 .
- Jablon , Seymour . June 14 1951 . “Testing of survival rates as computed from life tables,” June 14 , unpublished memorandum
- Kahn , H. A. and Mantel , Nathan . “Variance of estimated proportions withdrawing in single decrement follow-up studies when cases are lost from observation,” unpublished manuscript
- Littell , A. S. 1952 . “Estimation of the T-year survival rate from follow-up studies over a limited period of time,” . Human Biology , 24 : 87 – 116 .
- Seal , H. L. 1954 . “The estimation of mortality and other decremental probabilities,” . Skandinavisk Aktuarietidskrift , 37 : 137 – 62 .
Cited by
Sorted by citations
Items 501–600 of 1,378
Smith, S. M., Beau, M. M. L., Huo, D., Karrison, T. G., Sobecks, R. M., Anastasi, J., Vardiman, J. W., Rowley, J. D., & Larson, R. A. (2003) · Blood · doi:10.1182/blood-2002-11-3343 · Cited by 681
Total shoulder arthroplasty with the neer prosthesis: Long-term results
Torchia, M. E., Cofield, R. H., & Settergren, C. R. (1997) · Journal of Shoulder and Elbow Surgery · doi:10.1016/s1058-2746(97)90081-1 · Cited by 681
From Predictive to Prescriptive Analytics
Bertsimas, D., & Kallus, N. (2020) · Management Science · doi:10.1287/mnsc.2018.3253 · Cited by 784
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
Shipley, W. U., Seiferheld, W., Lukka, H. R., Major, P. P., Heney, N. M., Grignon, D. J., Sartor, O., Patel, M. P., Bahary, J.-P., Zietman, A. L., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607529 · Cited by 663
Clear cell carcinoma of the endometrium: Prognosis and metastatic pattern
Abeler, V. M., Vergote, I. B., Zzrstad, K. E. K., & Trope, C. G. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961015)78:8 · Cited by 144
Phase II Trial of Sorafenib in Advanced Thyroid Cancer
Abramson, V. G., Troxel, A. B., Nellore, A., Puttaswamy, K., Redlinger, M., Ransone, K., Mandel, S. J., Flaherty, K. T., Loevner, L. A., O'Dwyer, P. J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3279 · Cited by 674
Shiraki, M., Enterline, H. T., Brooks, J. J. S., Cooper, N. S., Hirschl, S., Roth, J. A., Rao, U. N. M., Enzinger, F. M., Amato, D. A., & Borden, E. C. (1989) · Cancer · doi:10.1002/1097-0142(19890715)64:2 · Cited by 68
Joint Injury in Young Adults and Risk for Subsequent Knee and Hip Osteoarthritis
Gelber, A. C., Hochberg, M. C., Mead, L. A., Wang, N., Wigley, F. M., & Klag, M. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-5-200009050-00007 · Cited by 676
Freschet, G. T., Pagès, L., Iversen, C. M., Comas, L. H., Rewald, B., Roumet, C., Klimešová, J., Zadworny, M., Poorter, H., Postma, J. A., et al. (2021) · New Phytologist · doi:10.1111/nph.17572 · Cited by 747
Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis
Vale, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13580-5 · Cited by 678
Trimbos, J. B., Vergote, I. B., Bolis, G., Vermorken, J. B., Mangioni, C., Madroñal, C., Franchi, M. P., Tateo, S., Zanetta, G. M., Scarfone, G., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.113 · Cited by 673
Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate Cancer
Halabi, S., Small, E. J., Kantoff, P. W., Kattan, M. W., Kaplan, E. B., Dawson, N. A., Levine, E. G., Blumenstein, B. A., & Vogelzang, N. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.100 · Cited by 673
Self-citationSinger, S., Antonescu, C. R., Riedel, E., & Brennan, M. F. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000086542.11899.38 · Cited by 672
Extracranial Stereotactic Radioablation *
Timmerman, R. D., Papiez, L. S., McGarry, R. C., Likes, L., DesRosiers, C. M., Frost, S. V., & Williams, M. D. (2003) · CHEST Journal · doi:10.1378/chest.124.5.1946 · Cited by 671
Green, M. R., Manikhas, G. M., Орлов, С. В., Afanasyev, B. V., Makhson, A. M., Bhar, P., & Hawkins, M. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl104 · Cited by 671
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods
Buse, J. B. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.003 · Cited by 661
Zincke, H., Oesterling, J. E., Blute, M. L., Bergstralh, E. J., Myers, R. P., & Barrett, D. M. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32399-6 · Cited by 669
Deep learning based tissue analysis predicts outcome in colorectal cancer
Bychkov, D., Linder, N., Turkki, R., Nordling, S., Kovanen, P. E., Verrill, C., Walliander, M., Lundin, M., Haglund, C., & Lundin, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21758-3 · Cited by 644
Exercise Treadmill Score for Predicting Prognosis in Coronary Artery Disease
Mark, D. B., Hlatky, M. A., HARRELL, F. E., LEE, K. L., Califf, R. M., & PRYOR, D. B. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-793 · Cited by 666
Guidelines for reporting mortality and morbidity after cardiac valve interventions
Akins, C. W., Miller, D. C., Turina, M. I., Kouchoukos, N. T., Blackstone, E. H., Grunkemeier, G. L., Takkenberg, J. J. M., David, T. E., Butchart, E. G., Adams, D. H., et al. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.12.002 · Cited by 664
Porschen, R., Lohe, B., Hengels, K. J., & Borchard, F. (1989) · Cancer · doi:10.1002/1097-0142(19891215)64:12 · Cited by 75
Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis
Colorectal Cancer Collaborative Group (2000) · BMJ · doi:10.1136/bmj.321.7260.531 · Cited by 662
Prognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
Stephenson, A. J., Scardino, P. T., Eastham, J. A., Bianco, F. J., Dotan, Z., DiBlasio, C. J., Reuther, A. M., Klein, E. A., & Kattan, M. W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.867 · Cited by 663
MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma
KLIMO, P., & Connors, J. M. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-5-596 · Cited by 662
Cognitive skills affect economic preferences, strategic behavior, and job attachment
Burks, S. V., Carpenter, J. P., Goette, L. F., & Rustichini, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812360106 · Cited by 659
Ciurea, S. O., Zhang, M., Bacigalupo, A. A., Bashey, A., Appelbaum, F. R., Aljitawi, O. S., Armand, P. A., Antin, J. H., Chen, J., Devine, S. M., et al. (2015) · Blood · doi:10.1182/blood-2015-04-639831 · Cited by 661
Bijker, N., Meijnen, P., Peterse, J. L., Bogaerts, J., Hoorebeeck, I. V., Julien, J.-P., Gennaro, M., Rouanet, P., Avril, A. R., Fentiman, I. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1366 · Cited by 658
Prognostic value of gated myocardial perfusion SPECT
Shaw, L. J., & Iskandrian, A. E. (2004) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2003.12.004 · Cited by 661
Scheithauer, W., Rosen, H., Kornek, G. V., Sebesta, C., & Depisch, D. (1993) · BMJ · doi:10.1136/bmj.306.6880.752 · Cited by 654
Savage, K. J. J., Johnson, N. A., Ben‐Neriah, S., Connors, J. M., Sehn, L. H., Farinha, P., Horsman, D. E., & Gascoyne, R. D. (2009) · Blood · doi:10.1182/blood-2009-05-220095 · Cited by 660
Clinical and biologic implications of recurrent genomic aberrations in myeloma
Fonseca, R., Blood, E., Rué, M., Harrington, D. P., Oken, M. M., Kyle, R. A., Dewald, G. W., Ness, B. V., Wier, S. A. V., Henderson, K. J., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3017 · Cited by 659
Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984
Katusic, S. K., Beard, C. M., Bergstralth, E., & Kurland, L. T. (1990) · Annals of Neurology · doi:10.1002/ana.410270114 · Cited by 657
Kempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643
Cavicchi, M., Beau, P., Crenn, P. P., Degott, C., & Messing, B. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00003 · Cited by 656
Siegel, D. S. D., Martin, T. G., Wang, M. L., Vij, R., Jakubowiak, A. J., Lonial, S., Trudel, S., Kukreti, V., Bahlis, N. J., Alsina, M., et al. (2012) · Blood · doi:10.1182/blood-2012-05-425934 · Cited by 664
Clinical spectrum of X-linked hyper-IgM syndrome
Levy, J., Espanol-Boren, T., Thomas, C., Fischer, A., Tovo, P., Bordigoni, P., Resnick, I., Fasth, A. L., Baer, M., Gomez, L., et al. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70123-9 · Cited by 656
Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension
Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., Gattobigio, R., Zampi, I., Reboldi, G., & Porcellati, C. (1998) · Circulation · doi:10.1161/01.cir.97.1.48 · Cited by 651
Lee, A. W., Poon, Y. F., Foo, W., Law, S. C. K., Cheung, F. K., Chan, D. K. K., Tung, S. Y., Thaw, M., & HO, J. H. C. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90740-9 · Cited by 652
Salem, R., Lewandowski, R. J., Kulik, L., Wang, E., Riaz, A., Ryu, R. K., Sato, K. T., Gupta, R., Nikolaidis, P., Miller, F. H., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.049 · Cited by 652
Brenner, D. J., Martinez, A. A., Edmundson, G. K., Mitchell, C. K., Thames, H. D., & Armour, E. P. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02664-5 · Cited by 650
Kyle, R. A., Linos, A., Beard, C. M., Linke, R. P., Gertz, M. A., O’Fallon, W. M., & Kurland, L. T. (1992) · Blood · doi:10.1182/blood.v79.7.1817.1817 · Cited by 650
DeepHit: A Deep Learning Approach to Survival Analysis With Competing Risks
Lee, C., Zame, W. R., Yoon, J., & van der Schaar, M. (2018) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v32i1.11842 · Cited by 651
Kemeny, N. E., DALY, J., REICHMAN, B., GELLER, N., BOTET, J., & ODERMAN, P. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-4-459 · Cited by 650
Witzig, T. E., Flinn, I. W., Gordon, L. I., Emmanouilides, C. E., Czuczman, M. S., Saleh, M. N., Cripe, L. D., Wiseman, G. A., Olejnik, T., Multani, P. S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.017 · Cited by 649
Roach, M., Bae, K., Speight, J. L., Wolkov, H. B., Rubin, P., Lee, R. J., Lawton, C. A., Valicenti, R. K., Grignon, D. J., & Pilepich, M. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9881 · Cited by 649
Wee, J. T. S., Tan, E. H., Tai, B. C., Wong, H. B., Leong, S. S., Tan, T., Chua, E. T., Yang, E., Lee, K. M., Fong, K. W., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.790 · Cited by 648
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance
Kyle, R. A., Larson, D. R., Therneau, T. M., Dispenzieri, A., Kumar, S., Cerhan, J. R., & Rajkumar, S. V. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709974 · Cited by 647
Depierre, A., Milleron, B. J., Moro‐Sibilot, D., Chevret, S., Quoix, É., Lebeau, B., Braun, D., Breton, J.-L., Lemarié, É., Gouva, S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.247 · Cited by 647
Lund, L. H., Edwards, L. B., Kucheryavaya, A. Y., Dipchand, A. I., Benden, C., Christie, J. D., Dobbels, F., Kirk, R., Rahmel, A. O., Yusen, R. D., et al. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.08.006 · Cited by 646
Blackstone, E. H., Naftel, D. C., & Turner, M. E. (1986) · Journal of the American Statistical Association · doi:10.1080/01621459.1986.10478314 · Cited by 646
Bonvalot, S., Rivoire, M. L., Castaing, M., Stoeckle, E., Cesne, A. L., Blay, J., & Laplanche, A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0802 · Cited by 644
Laharie, D., Bourreille, A., Branche, J., Allez, M., Bouhnik, Y., Filippi, J., Zerbib, F., Savoye, G., Nachury, M., Moreau, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61084-8 · Cited by 644
Choi, W. W. L., Weisenburger, D. D., Greiner, T. C., Piris, M. A., Banham, A. H., Delabie, J., Braziel, R. M., Geng, H., Iqbal, J., Lenz, G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0113 · Cited by 642
Primary liver cancer. An eastern cooperative oncology group trial
Falkson, G., MacIntyre, J. M., Moertel, C. G., Johnson, L. A., & Scherman, R. C. (1984) · Cancer · doi:10.1002/1097-0142(19840915)54:6 · Cited by 118
Fifteen-Year Cumulative Incidence of Age-Related Macular Degeneration
Klein, R., Klein, B. E. K., Knudtson, M. D., Meuer, S. M., Swift, M., & Gangnon, R. E. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.10.040 · Cited by 638
SURGICAL MANAGEMENT OF RENAL TUMORS 4 CM. OR LESS IN A CONTEMPORARY COHORT
Lee, C. T., Katz, J., Shi, W., Thaler, H. T., Reuter, V. E., & Russo, P. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67793-2 · Cited by 637
Nachemson, A. L., & Peterson, L. E. (1995) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199506000-00001 · Cited by 636
Moertel, C. G., Fleming, T. R., Creagan, E. T., Rubin, J., O'Connell, M. J., & Ames, M. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120301 · Cited by 637
Roach, M., DeSilvio, M., Lawton, C. A., Uhl, V., Machtay, M. X., Seider, M. J., Rotman, M., Jones, C. U., Asbell, S. O., Valicenti, R. K., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.004 · Cited by 634
Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1
Marlink, R., Kanki, P. J., Thior, I., Travers, K. U., Eisen, G., Siby, T., Traoré, I., Hsieh, C.-C., Dia, M., Gueye, E.-H., et al. (1994) · Science · doi:10.1126/science.7915856 · Cited by 634
HAY, I. D. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30310-4 · Cited by 633
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation
Flaker, G. C., Blackshear, J. L., McBride, R., Kronmal, R. A., Halperin, J. L., & Hart, R. G. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90003-6 · Cited by 633
Reducing the negative impact of radiation therapy on functional status
Johnson, J. E., Nail, L. M., Lauver, D., KING, K. B., & Keys, H. M. (1988) · Cancer · doi:10.1002/1097-0142(19880101)61:1 · Cited by 121
Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study
Niederau, C., Lange, S., Heintges, T., Erhardt, A., Buschkamp, M., Hürter, D., Nawrocki, M., Kruska, L., Hensel, F., Petry, W., et al. (1998) · Hepatology · doi:10.1002/hep.510280632 · Cited by 632
Prognosis of hepatocellular carcinoma
Marrero, J. A., Fontana, R. J., Barrat, A., Askari, F. K., Conjeevaram, H. S., Su, G. L., & Lok, A. S.-F. (2005) · Hepatology · doi:10.1002/hep.20636 · Cited by 632
Nelson, D. F., Martz, K. L., Bonner, H., Nelson, J. S., Newall, J., Kerman, H. D., Thomson, J. W., & Murray, K. J. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90538-s · Cited by 631
Multi-state models for event history analysis
Andersen, P. K., & Keiding, N. (2002) · Statistical Methods in Medical Research · doi:10.1191/0962280202sm276ra · Cited by 631
Investigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Smith, J. S., Tachibana, I., Passe, S. M., Huntley, B. K., Borell, T. J., Iturria, N. L., O'Fallon, J. R., Schaefer, P., Scheithauer, B. W., James, C. D., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.16.1246 · Cited by 630
Bone Marrow Transplantation in Patients with Thalassemia
Lucarelli, G., GALIMBERTI, M., Polchi, P., Angelucci, E., BARONCIANI, D., Giardini, C., Politi, P., Durazzi, S. M. T., Muretto, P., & Albertini, F. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220701 · Cited by 630
Evaluation of Power System Flexibility
Lannoye, E., Flynn, D., & O’Malley, M. (2012) · IEEE Transactions on Power Systems · doi:10.1109/tpwrs.2011.2177280 · Cited by 629
Henriques, J. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3035 · Cited by 628
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?
Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract, Takada, T., Amano, H., Yasuda, H., Nimura, Y., Matsushiro, T., Kato, H., Nagakawa, T., & Nakayama, T. (2002) · Cancer · doi:10.1002/cncr.10831 · Cited by 628
Lee, W. R., Dignam, J. J., Amin, M. B., Bruner, D. W., Low, D. A., Swanson, G. P., Shah, A. B., D'Souza, D. P., Michalski, J. M., Dayes, I. S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.0448 · Cited by 628
Buccheri, G., Ferrigno, D., & Tamburini, M. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00664-8 · Cited by 627
Paz-Ares, L. G., de Marinis, F., Dediu, M., Thomas, M., Pujol, J.-L., Bidoli, P., Molinier, O., Sahoo, T. P., Laack, E., Reck, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.1102 · Cited by 624
Intestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626
Larson, R. A., Dodge, R., Burns, C., Lee, E., Stone, R. M., Schulman, P., Duggan, D., Davey, F. R., Sobol, R., & Frankel, S. (1995) · Blood · doi:10.1182/blood.v85.8.2025.bloodjournal8582025 · Cited by 626
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer
Sause, W. T., Kolesar, P., Taylor, S. G., Johnson, D. H., Livingston, R. B., Komaki, R. R., Emami, B., Curran, W. J., Byhardt, R. W., Dar, A. R., et al. (2000) · CHEST Journal · doi:10.1378/chest.117.2.358 · Cited by 626
Sternberg, C. N., Yagoda, A., Scher, H. I., Watson, R. C., Herr, H. W., Morse, M. J., Sogani, P. C., Vaughan, E. D., Bander, N. H., Weiselberg, L. R., et al. (1988) · The Journal of Urology · doi:10.1016/s0022-5347(17)42494-3 · Cited by 625
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Barwell, J., Davies, C. E., Deacon, J., Harvey, K., Minor, J., Sassano, A., Taylor, M., Usher, J., Wakely, C., Earnshaw, J. J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16353-8 · Cited by 623
Geisler, C. H., Kolstad, A., Laurell, A., Andersen, N. S., Pedersen, L. B., Jerkeman, M., Eriksson, M., Nordström, M., Kimby, E. K., Boesen, A. M., et al. (2008) · Blood · doi:10.1182/blood-2008-03-147025 · Cited by 622
Remission of Seizures and Relapse in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Elveback, L. R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04857.x · Cited by 621
Reiter, A., Schrappe, M., Ludwig, W., Hiddemann, W., Sauter, S., Henze, G., Zimmermann, M., Lampert, F., Havers, W., & NIETHAMMER, D. (1994) · Blood · doi:10.1182/blood.v84.9.3122.3122 · Cited by 619
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
Rack, B., Schindlbeck, C., Jückstock, J., Andergassen, U., Hepp, P., Zwingers, T., Friedl, T. W. P., Lorenz, R., Tesch, H., Fasching, P. A., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju066 · Cited by 615
PEPE, M. S., & Mori, M. (1993) · Statistics in Medicine · doi:10.1002/sim.4780120803 · Cited by 617
Packer, R. J., Goldwein, J. L., Nicholson, H. S., Vezina, L. G., Allen, J. C., Ris, M. D., Muraszko, K. M., RORKE, L. B., Wara, W. M., Cohen, B. H., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2127 · Cited by 616
Mitsiades, C. S., Mitsiades, N., McMullan, C. J., Poulaki, V., Shringarpure, R., Akiyama, M., Hideshima, T., Chauhan, D., Joseph, M. G., Libermann, T. A., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00050-9 · Cited by 614
A genetic basis for familial aggregation in multiple sclerosis
Ebers, G. C., Sadovnick, A. D., & RISCH, N. J. (1995) · Nature · doi:10.1038/377150a0 · Cited by 608
Cascone, T., William, W. N., Weissferdt, A., Leung, C. H., Lin, H. Y., Pataer, A., Godoy, M. C. B., Carter, B. W., Federico, L., Reuben, A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01224-2 · Cited by 618
Durability of mitral valve repair for degenerative disease
Gillinov, A. M., Cosgrove, D. M., Blackstone, E. H., Diaz, R., Arnold, J. H., Lytle, B. W., Smedira, N. G., Sabik, J. F., McCarthy, P. M., & Loop, F. D. (1998) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)00450-4 · Cited by 613
Groome, P. A., Bolejack, V., Crowley, J. J., Kennedy, C. W., Krasnik, M., Sobin, L. H., & Goldstraw, P. G. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812d05d5 · Cited by 613
Prisé, É. L., Etienne, P. L., Meunier, B., Maddern, G. J., Hassel, M. B., Gedouin, D., Boutin, D., Campion, J. P., & Launois, B. (1994) · Cancer · doi:10.1002/1097-0142(19940401)73:7 · Cited by 612
Orban, T., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Marks, J. B., Monzavi, R., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60886-6 · Cited by 612
Lai, S.-Z., Li, W., Chen, L., Luo, W., Chen, Y., Liu, L., Sun, Y. H., Lin, A., Liu, M., & Ma, J. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.03.024 · Cited by 611
Möricke, A., Reiter, A., Zimmermann, M., Gadner, H., Stanulla, M., Dördelmann, M., Löning, L., Beier, R., Ludwig, W.-D., Ratei, R., et al. (2008) · Blood · doi:10.1182/blood-2007-09-112920 · Cited by 611
Thuss-Patience, P. C., Kretzschmar, A., Bichev, D., Deist, T., Hinke, A., Breithaupt, K., Dogan, Y., Gebauer, B., Schumacher, G., & Reichardt, P. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.002 · Cited by 611
Metadata
- Authors
- Kaplan, E. L., & Meier, P.
- Affiliations
- University of California Radiation Laboratory
- University of Chicago (US)
- Venue
- Journal of the American Statistical Association
- Publisher
- Informa UK Limited
- Published
- 1958-06
- Volume
- 53
- Issue
- 282
- Pages
- 457-481
- ISSN
- 0162-1459 (ISSN-L)
- 1537-274X
- OpenAlex
- W4293241248
- Cited by
- 39,158
- References
- 16
- Citations by year
- 2026: 886 · 2025: 862 · 2024: 915 · 2023: 1025 · 2022: 1026 · 2021: 1078 · 2020: 1028 · 2019: 909 · 2018: 944 · 2017: 965 · 2016: 950 · 2015: 961 · 2014: 1137 · 2013: 1046 · 2012: 1056
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Statistical Association (publishedVersion)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Distribution Estimation and Applications
- Physical Sciences › Mathematics › Statistics and Probability › Probability and Statistical Research
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Inference
- Keywords
- nonparametric estimation, censored data, survival analysis, Kaplan-Meier estimator, lifetime distributions, clinical follow-up
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review